Last 335.30 INR
Change Today +16.40 / 5.14%
Volume 23.6K
JBP On Other Exchanges
Symbol
Exchange
Mumbai
As of 5:14 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

jenburkt pharmaceuticals (JBP) Snapshot

Open
320.00
Previous Close
318.90
Day High
342.00
Day Low
317.80
52 Week High
11/12/14 - 390.20
52 Week Low
01/2/14 - 77.80
Market Cap
1.6B
Average Volume 10 Days
8.5K
EPS TTM
13.37
Shares Outstanding
4.6M
EX-Date
09/3/14
P/E TM
25.1x
Dividend
5.10
Dividend Yield
1.51%
Current Stock Chart for JENBURKT PHARMACEUTICALS (JBP)

Related News

No related news articles were found.

jenburkt pharmaceuticals (JBP) Related Businessweek News

No Related Businessweek News Found

jenburkt pharmaceuticals (JBP) Details

Jenburkt Pharmaceuticals Ltd. manufactures and markets pharmaceutical formulations and healthcare products in India and internationally. It primarily offers prescription medicines across various therapeutic areas, such as anti-arthritic, antimalarials, anti-osteoporotic, antibiotics, antidiabetics, anti-inflammatory drugs, gastro intestinal, dermatological, aphrodisiac, anti-ulcerant drugs, anti-hypertensive, anthelmintics, hematinics, neuropathy, and protein preparation, as well as over-the-counter drugs. The company was founded in 1985 and is based in Mumbai, India.

Founded in 1985

jenburkt pharmaceuticals (JBP) Top Compensated Officers

Chairman, Managing Director, Member of Stakeh...
Total Annual Compensation: 7.8M
Chief Financial Officer, Whole Time Director,...
Total Annual Compensation: 1.3M
Compensation as of Fiscal Year 2014.

jenburkt pharmaceuticals (JBP) Key Developments

Jenburkt Pharmaceuticals Ltd. Appoints Devangi Sanjeev Shah as Non-Executive and Independent Director

Jenburkt Pharmaceuticals Ltd. announced that Ms. Devangi Sanjeev Shah has been appointed, subject to consent of the Members, as a non-executive and Independent Director of the Company, for a term of five years i.e. from November 11, 2014 to November 10, 2019, by the Board of Directors at their meeting held on November 11, 2014.

Jenburkt Pharmaceuticals Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Half Year Ended September 30, 2014

Jenburkt Pharmaceuticals Ltd. reported unaudited standalone earnings results for the second quarter and half year ended September 30, 2014. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 222.240 million against INR 197.487 million a year ago. Profit from operations before other income, finance costs & exceptional items was INR 40.373 million against INR 29.878 million a year ago. Profit from ordinary activities before tax was INR 42.350 million against INR 31.564 million a year ago. Net profit was INR 32.475 million or INR 6.98 per basic and diluted share against INR 23.064 million or INR 4.96 per basic and diluted share a year ago. For the half year, the company reported net sales/income from operations (net of excise duty) of INR 414.333 million against INR 367.842 million a year ago. Profit from operations before other income, finance costs & exceptional items was INR 61.758 million against INR 48.648 million a year ago. Profit from ordinary activities before tax was INR 63.232 million against INR 45.424 million a year ago. Net profit was INR 47.357 million or INR 10.19 per basic and diluted share against INR 32.424 million or INR 6.97 per basic and diluted share a year ago.

Jenburkt Pharmaceuticals Ltd., Board Meeting, Nov 11, 2014

Jenburkt Pharmaceuticals Ltd., Board Meeting, Nov 11, 2014. Agenda: To approve quarterly results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JBP:IN 335.30 INR +16.40

JBP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JBP.
View Industry Companies
 

Industry Analysis

JBP

Industry Average

Valuation JBP Industry Range
Price/Earnings 17.1x
Price/Sales 1.9x
Price/Book 4.8x
Price/Cash Flow 14.4x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JENBURKT PHARMACEUTICALS, please visit www.jenburkt.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.